Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Metabolic syndrome is a cluster of metabolic abnormalities that increases the risk of cardiovascular disease and other chronic conditions. According to Zahra Jamali et al., epidemiological studies have reported a global prevalence of approximately 5–7% among young people. According to the metabolic syndrome epidemiology forecast by Expert Market Research, the prevalence of metabolic syndrome remains an important epidemiological indicator.
Base Year
Historical Period
Forecast Period

Read more about this report - Request a Free Sample
Expert Market Research's “Metabolic Syndrome Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of metabolic syndrome. It projects the future incidence and prevalence rates of metabolic syndrome cases across various populations. The study covers age, gender, and type as major determinants of the metabolic syndrome population. The report highlights patterns in the prevalence of metabolic syndrome over time and projects future trends based on multiple variables.
The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of metabolic syndrome in the 8 major markets.
Regions Covered
Metabolic syndrome is a cluster of interrelated metabolic abnormalities that collectively increase the risk of cardiovascular disease, type 2 diabetes, and other complications. It generally involves abdominal obesity, elevated blood pressure, elevated blood glucose, high triglyceride levels, and reduced high-density lipoprotein cholesterol. The condition develops through interacting factors such as insulin resistance, excess visceral fat, physical inactivity, genetic susceptibility, and unhealthy dietary patterns. Metabolic syndrome is not classified into distinct clinical types; rather, patients may present with different combinations and severity of its components. Insulin resistance is a central underlying mechanism.
|
Parameter |
Insight |
|
Largest Patient Pool |
United States |
|
Fastest Growing Country |
India |
|
High-Risk Population |
Individuals with obesity, older adults, and people with sedentary lifestyles |
|
Key Diagnostic Method |
Assessment of metabolic syndrome components, including waist circumference, blood pressure, blood glucose, triglycerides, and high-density lipoprotein cholesterol |
|
Major Risk Factor |
Abdominal obesity and insulin resistance |
|
Major gap in the market |
Underdiagnosis and inconsistent identification of individuals with multiple metabolic risk factors |
The metabolic syndrome epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the metabolic syndrome epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for metabolic syndrome and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
|
Epidemiology Segment |
Key Insights |
|
Diagnosed Prevalent Cases of the Disease |
According to Jean Jacques Noubiap et al. (2025), global MetS prevalence increased from 14.7% among women and 9.0% among men in 2000 to 31.0% and 25.7%, respectively, in 2023. An estimated 1.54 billion adults had MetS in 2023. |
|
Gender-Specific Cases of the Disease |
As per Jean Jacques Noubiap et al. (2025), 846 million women and 692 million men were estimated to have MetS globally in 2023. Prevalence was higher among women than men in 102 countries, although the magnitude of sex differences varied substantially across countries. |
|
Age-Specific Cases of the Disease |
According to Jean Jacques Noubiap et al. (2025), MetS prevalence increased with age globally. P Swarna Latha et al. (2024) reported a prevalence of 39.8% in a study population with a mean age of 44.97 years, with age above 40 independently associated with MetS. |
|
Ethnicity-Wise Cases of the Disease |
According to Nia Heard-Garris et al. (2024), approximately one in three people in the United States has MetS, with racially and ethnically minoritized groups reported to have the highest prevalences. The available data indicate substantial variation in MetS burden across population groups. |
|
Mortality and Survival Analysis of the Disease |
According to Zahra Jamali et al., MetS in young people is relevant to future cardiovascular disease and associated mortality. Global prevalence reached 31.0% among women and 25.7% among men in 2023, indicating a substantial and increasing population-level burden. |

Read more about this report - Request a Free Sample
The metabolic syndrome epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.
|
Country |
Key Insights |
|
United States |
According to Nia Heard-Garris et al. (2024), approximately one in three people in the United States has metabolic syndrome. The epidemiological burden is associated with obesity, physical inactivity, and differences across racial and ethnic population groups. |
|
Germany |
According to the Bundesministerium für Gesundheit, 25% of adults in Germany are severely overweight and therefore at risk of developing metabolic syndrome. European epidemiological data also indicate variation in metabolic syndrome component patterns across German populations. |
|
France |
According to Jean Jacques Noubiap et al. (2025), France demonstrated a higher metabolic syndrome prevalence among men than women, with the absolute sex difference reaching −36.7%. Differences in age, obesity, metabolic risk factors, and population characteristics contribute to epidemiological variation. |
|
Italy |
According to Jean Jacques Noubiap et al. (2025), metabolic syndrome prevalence has increased across countries globally. European data indicate distinct metabolic syndrome component patterns in Italy, with the glucose–blood pressure–body-weight cluster accounting for 31.4% in Southern European cohorts. |
|
Spain |
According to Leila Lujan-Barroso et al. (2023), metabolic syndrome prevalence in Spain was approximately 40% among older men and 32% among older women. The epidemiological burden is associated with increasing obesity, insulin resistance, and type 2 diabetes prevalence. |
|
United Kingdom |
According to Jean Jacques Noubiap et al. (2025), metabolic syndrome prevalence has increased globally, with prevalence influenced by age, urbanization, and income. In the United Kingdom, population-level burden is also supported by high levels of obesity and related metabolic risk factors. |
|
Japan |
The epidemiological burden of metabolic syndrome in Japan is influenced by age-related metabolic risk, obesity, glucose abnormalities, blood pressure, and lipid disturbances. Population aging and changes in metabolic risk profiles are relevant factors shaping the country's epidemiological pattern. |
|
India |
According to P Swarna Latha et al. (2024), metabolic syndrome prevalence was 39.8% in the study population. Being older than 40 years, physical inactivity, and obesity were independently associated with metabolic syndrome, indicating important age and lifestyle-related epidemiological factors. |
A major gap in the metabolic syndrome epidemiology landscape is the inconsistent identification of individuals who have multiple cardiometabolic risk factors but have not yet developed overt diabetes or cardiovascular disease. Opportunities exist to strengthen routine screening for abdominal obesity, hypertension, dyslipidemia, and impaired glucose regulation, particularly among high-risk populations. India represents an important emerging growth area because changing dietary patterns, urbanization, physical inactivity, and increasing obesity can contribute to cardiometabolic risk. Across the United States, European countries, Japan, and India, integrated prevention strategies and earlier risk identification could support improved disease management and reduce progression to associated chronic conditions.
Treatment for metabolic syndrome focuses on reducing the individual risk factors and preventing progression to cardiovascular disease and type 2 diabetes. Lifestyle modification is the foundation of management and includes weight reduction, regular physical activity, a balanced diet, smoking cessation, and moderation of alcohol intake. Depending on the patient's risk profile, medications may be used to control hypertension, hyperglycemia, dyslipidemia, or obesity. Management is generally individualized according to the predominant abnormalities and overall cardiovascular risk. Lifestyle intervention remains an important component of long-term disease management.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
|
Report Features |
Details |
|
Base Year |
2025 |
|
Historical Period |
2019-2025 |
|
Forecast Period |
2026-2035 |
|
Epidemiology Statistics Provided |
|
|
Segmentation Provided |
|
|
Geographies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.